← Back to directory

Flávio Kapczinski

Researcher Next ID · RN-022636

Researcher · Medicine

Universidade Federal do Rio Grande do Sul

Porto Alegre, Brazil

Not currently recruitingFunding unknown
Works count
969
Citation count
43,852
H-index
107
i10-index
506

Research interests

Medicine
Neuroscience
Bipolar Disorder and Treatment
Tryptophan and brain disorders
Schizophrenia research and treatment
Electroconvulsive Therapy Studies
Treatment of Major Depression

Publications

  • Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

    Own your potential (DEAKIN) · 2019 · https://doi.org/10.3760/cma.j.issn.1006-7884.2019.01.101

  • Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder

    Bipolar Disorders · 2018 · https://doi.org/10.1111/bdi.12609

  • Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression

    The Lancet Psychiatry · 2015 · https://doi.org/10.1016/s2215-0366(15)00309-0

  • Staging systems in bipolar disorder: an I nternational S ociety for B ipolar D isorders T ask F orce R eport

    Acta Psychiatrica Scandinavica · 2014 · https://doi.org/10.1111/acps.12305

  • Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force

    Australian & New Zealand Journal of Psychiatry · 2013 · https://doi.org/10.1177/0004867413478217

  • The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders

    American Journal of Psychiatry · 2013 · https://doi.org/10.1176/appi.ajp.2013.13020185

  • The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial

    Journal of Affective Disorders · 2011 · https://doi.org/10.1016/j.jad.2011.06.005

  • Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

    Neuropsychopharmacology · 2011 · https://doi.org/10.1038/npp.2011.6

  • Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

    Neuroscience & Biobehavioral Reviews · 2010 · https://doi.org/10.1016/j.neubiorev.2010.10.001

  • The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders

    Bipolar Disorders · 2009 · https://doi.org/10.1111/j.1399-5618.2009.00726.x

  • Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009

    Bipolar Disorders · 2009 · https://doi.org/10.1111/j.1399-5618.2009.00672.x

  • Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder

    Acta Psychiatrica Scandinavica · 2007 · https://doi.org/10.1111/j.1600-0447.2007.01058.x

  • Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder

    Clinical Practice and Epidemiology in Mental Health · 2007 · https://doi.org/10.1186/1745-0179-3-5

Current projects

    No projects listed.